Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Quest Diagnostics Inc (DGX) – Quest Diagnostics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Quest Diagnostics (DGX) trades at $204.97, up 5.1% on the day, with a bullish technical signal and recent earnings beats in three of the last four quarters. The stock shows solid profitability with a net margin of 8.99% and ROE of 14.17%, supported by steady revenue near $9.9 billion in 2024. Recent developments include AI integration for lab results and partnerships for cancer diagnostics, enhancing its diagnostic services leadership.
The outlook is cautiously optimistic with a consensus price target of $219.29, offering potential upside. Risks include a recent earnings miss and rising debt-to-asset ratio to 39.78% in 2024. Institutional activity is mixed, with some increasing stakes while others reduce positions, reflecting balanced sentiment amid competitive pressures.
Read full analysis

Key Stats

  • Market Cap
    $21.73B
  • Sector
    Health
  • 3M Drawdown
    -9.67%
  • Enterprise Value
    $27.89B
  • Dividend Yield
    1.75%
  • Typical Hold Time
    68 days
$208.53
52W Low: $161.86
21 Apr 2025
52W High: $211.91
27 Feb 2026

Quest Diagnostics Inc (DGX) is currently valued at a market capitalization of $21.73B, with an enterprise value of $27.89B. Over the past 52 weeks, Quest Diagnostics Inc has traded between a low of $161.86 and a high of $211.91, highlighting its annual price range. Over the past three months, Quest Diagnostics Inc has recorded a drawdown of -9.67%, reflecting recent price volatility. Quest Diagnostics Inc offers a dividend yield of 1.75%, with the most recent dividend of $0.86 paid on 06 Apr 26. On average, investors hold Quest Diagnostics Inc for approximately 68 days, indicating typical investor behavior on the platform.

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.


Technical Indicators
|
|
|
Overall Summary
Bearish (7)Neutral (3)Bullish (17)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $21.73B
  • Sector
    Health
  • 3M Drawdown
    -9.67%
  • Enterprise Value
    $27.89B
  • Dividend Yield
    1.75%
  • Typical Hold Time
    68 days
$208.53
52W Low: $161.86
21 Apr 2025
52W High: $211.91
27 Feb 2026

Quest Diagnostics Inc (DGX) is currently valued at a market capitalization of $21.73B, with an enterprise value of $27.89B. Over the past 52 weeks, Quest Diagnostics Inc has traded between a low of $161.86 and a high of $211.91, highlighting its annual price range. Over the past three months, Quest Diagnostics Inc has recorded a drawdown of -9.67%, reflecting recent price volatility. Quest Diagnostics Inc offers a dividend yield of 1.75%, with the most recent dividend of $0.86 paid on 06 Apr 26. On average, investors hold Quest Diagnostics Inc for approximately 68 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!